Market›Health Care›Biotechnology›Biotechnology
AXIM BIOTECHNOLOGIES

AXIM

$0.01Apr 26, 2021 – Apr 24, 2026
Health CareBiotechnology$2M
MVM
+$0.1M
TD Variance
1.500

Every news event mapped to its market reaction — 35 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-10-15-33.0%legalSEC EDGARAXIM 8-K: 5.01 and 5.02 (SEC Filing)
2024-10-15-33.0%M&AInvesting.comAxim biotechnologies' president Valencia Catalina acquires 1.08 million shares - Investing.com
2022-02-16+32.4%legalSEC EDGARAXIM 8-K: 1.01, 1.02, 2.03, 3.02 (SEC Filing)
2021-05-05+21.8%newsGlobeNewswireAXIM® Biotechnologies’ Manufacturing Partner Empowered - GlobeNewswire
2025-04-25+19.2%newsStock TitanENZC Stock Price, News & Analysis | Enzolytics - Stock Titan
2022-10-04-18.2%newsSeeking AlphaAxim stock rises 11% on diagnostic tests order with partner Versa
2021-05-14-17.2%legalSEC EDGARAXIM 8-K: 1.01 and (SEC Filing)
2022-08-29+16.0%legalSEC EDGARAXIM 8-K: 1.01, 3.02 (SEC Filing)
2022-01-07-14.2%legalSEC EDGARAXIM 8-K: 5.02 (SEC Filing)
2022-09-19+14.0%legalSEC EDGARAXIM 8-K: 1.01, 7.01 (SEC Filing)
2021-08-04+13.9%legalSEC EDGARAXIM 8-K: 1.01, 7.01 (SEC Filing)
2022-11-21-11.2%newsGuruFocusLekhram Changoer Net Worth (2026) - GuruFocus
2024-02-13-10.0%legalSEC EDGARAXIM 8-K: 1.01 and 3.02 (SEC Filing)
2021-10-05-9.0%executiveGlobeNewswireAXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board - GlobeNewswire
2022-01-12-8.3%legalSEC EDGARAXIM 8-K: 5.02 (SEC Filing)
2023-05-30-8.2%legalSEC EDGARAXIM 8-K: 1.01, 2.03 (SEC Filing)
2022-03-08-8.2%newsSeeking AlphaAXIM Biotechnologies develops test for biomarker of dry eye disease
2022-07-21+6.4%newsGlobeNewswireAXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast - GlobeNewswire
2023-12-28-4.7%legalSEC EDGARAXIM 8-K: 1.01, 3.02 (SEC Filing)
2022-11-09-3.3%newsGuruFocusFoundation Sanammad Net Worth (2026) - GuruFocus
2023-06-02+3.1%legalSEC EDGARAXIM 8-K: 1.01 and (SEC Filing)
2021-05-26-3.1%newsSeeking AlphaAXIM completes pre-clinical studies on SPX-1009 in suppression of melanoma cells
2021-08-30+2.9%newsGlobeNewswireAXIM® Biotechnologies’ Manufacturing Partner Empowered - GlobeNewswire
2025-04-24-2.8%newsStock TitanSRNE Stock Price, News & Analysis - Stock Titan
2023-05-25-2.2%legalSEC EDGARAXIM 8-K: 5.02 and (SEC Filing)
2021-08-03+1.2%M&AGlobeNewswireAXIM® Biotechnologies to Acquire Technology Including Two - GlobeNewswire
2023-01-27+1.0%legalSEC EDGARAXIM 8-K: 1.01, 2.03 (SEC Filing)
2026-01-29+0.5%newsNewMediaWireAXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
2026-01-29+0.5%newsNewMediaWireMedical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
2026-01-29+0.5%newsYahoo FinanceAXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids - Yahoo Finance
2026-01-29+0.5%newsYahoo FinanceMedical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids - Yahoo Finance
2024-03-21-0.1%legalSEC EDGARAXIM 8-K: 1.01, 2.03 (SEC Filing)
2021-10-11+0.1%executiveSeeking AlphaAXIM Biotechnologies appoints Henry Perry to Medical Advisory Board
2021-10-11+0.1%executiveGlobeNewswireAXIM® Biotechnologies Appoints Leading US Ophthalmic - GlobeNewswire
2021-10-12-0.1%newsGlobeNewswireAXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19 - GlobeNewswire
tickerdossier.comtickerdossier.substack.com